|
126 |
Guidance on the Booster Strategy for Vaccine Recipients with Sinopharm as Primary Dose Series |
October 25, 2022 |
|
162 |
Advisory on the Applicable DOH Policies on COVID-19 Vaccination and NVOC Advisories |
June 30, 2022 |
|
164 |
Guidance on the Administration of Additional Dose of Pfizer BioNTech COVID-19 Vaccine to the Non - Immunocompromised Pediatric A3 and Rest of the Pediatric Population ages 12-17 years old |
June 29, 2022 |
|
163 |
Advisory on the Transfer of the Functions of the National Vaccination Operations Center to the Public Health Services Team, Department of Health |
June 27, 2022 |
|
161 |
Guidance on the Interval of Depot MedroxyProgesterone Acetate (DMPA) Injection with COVID-19 Vaccination |
June 22, 2022 |
|
160 |
Guidance on the Booster Strategy for COVID-19 vaccine Recipients with Heterologous Primary Dose Series |
June 15, 2022 |
|
159 |
Dissemination of Updated “RESBAKUNA Updates: Town Hall for Barangay Health Workers (BHWs)” Materials & Presentations |
June 03, 2022 |
|
158 |
Advisory on Archiving of the Vaccination Reports through the DICT Vaccination Operations Reporting System (VORS) |
May 31, 2022 |
|
156 |
Urgent Reminders in Ramping Up COVID-19 Vaccination in View of Omicron BA.4 Subvariant in the Country |
May 23, 2022 |
|
155 |
Further Guidance to Address the Latest Concerns on the National COVDI-19 Vaccine Deployment and Vaccination Program |
May 20, 2022 |
|
154 |
Guidance on the Vaccination Rollout for Second Booster Doses to Priority Groups A1: Workers in Essential Health Services and A2: Senior Citizens |
May 19, 2022 |
|
153 |
Guidance on the Length of Safekeeping of Informed Consent Forms for COVID-19 Pediatric Vaccinations For Ages 5-17 |
May 13, 2022 |
